Fig. 2

Tumor suppressors network associated with the BCR-ABL/MAPK pathway. Representation of the tumor suppressors involved in the RAS/MEK/ERK pathway and the JAK2/β-catenin pathway. DOK family proteins are involved in the negative regulation of RAS activation. Representation of the IRF pathway. Finally, morgana/chp-1 pathway is indicated